Livingstone Health maps expansion plans
It is taking a cautious approach by focussing on boosting offerings as a multidisciplinary specialist healthcare group; signing MOUs to evaluate projects in Asia
Singapore
WHILE there are many high growth opportunities in the healthcare sector, Catalist-listed Livingstone Health is opting to take a cautious approach by focussing on boosting its offerings as a multidisciplinary specialist healthcare group.
The group had listed on the Singapore Exchange (SGX) just two months ago via a S$72 million reverse takeover (RTO). The RTO involved a 500-to-1 consolidation of the former Citicode's share base and the transfer of its listing status from SGX's mainboard to the Catalist board.
"As much as we want to look and venture into things which are exciting, there's also a lot of risk," said chief business officer Dax Ng in a media briefing on Tuesday.
Telemedicine, for instance, is an area many healthcare players have jumped into. While Livingstone has started adopting telemedicine, it is still in talks with key partners to better understand how patients a…
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Middle East violence heightens market fears of rate hikes, inflation
Tokyo's Nikkei drops more than 1,000 points, most in 3 years
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Inside TSMC chairman Mark Liu's short but impactful reign
CSE Global bags US$36.5 million data centre contract extension